MUMBAI : Adding to the spree of private equity investments in the Indian pharmaceutical sector, India Life Sciences Fund III has invested ₹100 crore in Inventia Healthcare Ltd.Inventia, with its R&D centre and manufacturing facilities close to Mumbai, develops and manufactures oral solid formulations.
The company is also venturing into injectables and nutraceuticals.“This infusion of funds will be used as growth capital for our pharma and nutraceutical business, and further strengthen our balance sheet through deleveraging and accelerate our goal of becoming a debt-free company," said Janak Shah, chairman and managing director of Inventia.According to Sumit Gupta, director at InvAscent, the investment adviser to India Life Sciences Fund.